Catalent and Valerion Therapeutics Collaborate to Bring New Treatments for Orphan Genetic Disorders to Market

Somerset, N.J. (PRWEB) December 02, 2014 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is to collaborate with Valerion Therapeutics, LLC, an emerging science-driven company, focused on the development of bio-therapeutics for orphan genetic diseases, to develop Valerion’s ...